Although alpha-glucosidase inhibitors are effective hypoglycemic drugs working in the GI tract, the link between them and colorectal adenoma formation remains unexplored. A retrospective cross-sectional study was conducted on type 2 diabetes patients aged 60 and above using data from Wenzhou Central ...
The Evolution of Glucose-Lowering Drugs for Type 2 Diabetes Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome Book2012, Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome Andrew J. Krentz, Alan J. Sinclair Explore book Alpha-Glucosidase Inhibitors Alpha...
To manage type 2 diabetes and its associated problems, α-glucosidase inhibitors (AGIs) are extensively used. This class of oral hypoglycemic agents includes the drugs such as acarbose, miglitol, and voglibose. The drawbacks of these AGIs are the strict and repetitive dosing schedule and a high ...
The Alpha-glucosidase Inhibitors Market size is estimated at USD 4.76 billion in 2024, and is expected to reach USD 5.30 billion by 2029, growing at a CAGR of 2.17% during the forecast period (2024-2029). Alpha-glucosidase inhibitors are oral anti-diabetic drugs used for diabetes mellitus typ...
France is Expected to Dominate the Europe Alpha-Glucosidase Inhibitors Market. Although alpha-glucosidase inhibitors are studied as monotherapy and as part of a combination regimen for treating diabetes, they are not considered standard first-line therapy due to their low efficacy and poor tolerance. ...
GLUCOSIDASE inhibitorsMICROCRYSTALLINE polymersCELLULOSELICHENSDRUGSEXTRACTSObjective: Microcrystalline cellulose (MCC) is an excipient commonly used in the ... CB Putri,Sutriyo,H Suryadi - 《Pharmacognosy Journal》 被引量: 0发表: 2019年 加载更多研究...
Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. OBJECTIVE: To review the effects of monotherapy with alpha-glucosidase inhibitors (AGIs) for patients with type 2 diabetes, with respect to mortality, morb... AL Floris,HL ...
Thus, DPP-4 inhibitors may be safe drugs for patients with type 2 diabetes. Study limitations The first limitation of this study was the small sizes of the groups. The second was heterogeneity of the population in this study. The age range was quite wide in our study. The third limitation...
Background and purpose: Alpha- glucosidase inhibitors are used in treatment of type 2 diabetes because they decrease postprandial hyperglycemia. Consistent use of these drugs has undesirable side effects such as liver toxicity and gastrointestinal symptoms. The purpose of this study was to investigate ...
It has been recently reported that, while the pyrrolidine based monovalent reference compounds31and32(Fig. 9), are negligible inhibitors, their nonavalent compounds30and33(Fig. 9) show remarkable inhibitory activities towards both GALNS and IDS, with IC50in the micromolar range when the inhibitory ...